Companies /Healthcare

Merck & Co Inc

NYSE: MRK Drug Manufacturers - General
$143.93
▼ $0.78 (−0.54%) today
Markets closed · 3:26pm ET

MRK Coverage

Page 70
8:57am ET
Health and Healthcare

Merck Bares All In Pipeline Presentation (MRK)

Merck & Co., Inc. (NYSE: MRK) today outlined its drug pipeline and has reaffirmed its guidance given last week.  Merck plans to emerge next year and into the next decade leaner and…

MRK
Douglas A. McIntyre
9:06am ET
Jobs

DJIA Losing 3 Trifecta (T, DD, MRK)

It is easy to get pumped up about overseas rate cuts, but there is cautionary data from at least three DJIA components.  Wal-Mart is the economic trade-down so that win in retail…

DD MRK T
Douglas A. McIntyre
7:29am ET
Health and Healthcare

Merck (MRK): People Won’t Even Buy Drugs

So much fore feeling better in a bad economy. Merck (MRK) offered lackluster guidance for next year and the stock is off before the open. According to Reuters, "Merck said it expected…

MRK
Douglas A. McIntyre
9:24am ET
Health and Healthcare

Biotech Implosion: Dynavax (DVAX)

Dynavax Technologies Corp. (NASDAQ: DVAX) is the latest biotech implosion as shares are down some 75% today.  The company gave an update on an FDA clinical hold on its investigational vaccine HEPLISAV…

Douglas A. McIntyre
5:24am ET
Health and Healthcare

Merck (MRK): More Trouble With Vioxx

A lot of people believe that Merck (MRK) knew a lot more about the dangers of its arthritis drug Vioxx than the company ever let on. Heart problems were apparently a by-product…

MRK
Douglas A. McIntyre
8:11am ET
Health and Healthcare

More Blight For Merck (MRK)

Merck (MRK) and Schering-Plough (SGP) make two of the most widely sold drugs in the world. One is cholesterol drug Zetia. Another is a related drug called Vytorin. The sales of the…

MRK
Douglas A. McIntyre